MENUAbout the Institute
The Forbes Institute for Cancer Discovery empowers scientists across U-M to pursue high-risk, high-reward projects with the potential to advance research from the laboratory to the clinic. By providing bold, cross-departmental funding opportunities, we are fueling new and innovative approaches to prevention, early diagnosis, and treatment of cancer.
Our Mission:
Aggressively advance scientific discoveries to clinical applications that better prevent, treat, and cure cancer.
Our Vision:
- Catalyze scientific innovation, business, and philanthropy
- Empower physicians, engineers, chemists, computer scientists, mathematicians, physicists, and others across campus to pursue high-risk, high-reward cancer research
- Leapfrog lag time between new concepts, discovery, and optimization
- Overcome the funding gap for translational research (while we are consistently among the leaders in research funding from the National Cancer Institute, only a small fraction of grants awarded by the National Cancer Institute support translational research)
- Leverage the breadth and depth of expertise at U-M, which is unmatched by freestanding cancer centers
Our Director:
Max S. Wicha, M.D.
Madeline and Sidney Forbes Professor of Oncology
Director, Forbes Institute for Cancer Discovery
Founder and Director Emeritus of the U-M Rogel Cancer Center
Learn more about the Forbes gift: Forbes’ $17.5 Million Gift to Stimulate Cancer Research